Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
prodrug
Pharma
FDA approves Ascendis' achondroplasia treatment Yuviwel
The FDA has approved Ascendis' Yuviwel, a once-weekly injection to treat children with achondroplasia, a rare genetic disorder that causes dwarfism.
Kevin Dunleavy
Mar 2, 2026 9:25am
Alpha Cognition's Alzheimer's drug passes muster with FDA
Jul 29, 2024 9:34am
Alpha Cognition's delayed-release Alzheimer's drug hits goal
Aug 23, 2022 10:32am
Avacta's doxorubicin prodrug clears another early safety test
Jul 5, 2022 9:03am
